Low-Dose Steroid Therapy Is Associated with Decreased IL-12 Production in PBMCs of Severe Septic Patients
Table 3
Cytokine responses (pg/mL, mean ± standard error mean) on days 1 and 7 in no-low-dose steroid, low-dose steroid, and control groups.
No-low-dose steroid ()
Low-dose steroid ()
All patients ()
Controls ()
Day 1
IL-1
182.0 ± 18.6
200.0 ± 5.6
193.1 ± 7.8
110.8 ± 8.3†
IL-6
375.0 ± 40.2
416.2 ± 13.8
400.6 ± 17.5
385.4 ± 31.7
IL-10
340.4 ± 84.6
333.1 ± 74.1
335.8 ± 55.1
305.5 ± 29.4
IL-12
514.1 ± 151.8
141.3 ± 39.5
282.7 ± 69.9
266.6 ± 50.5
IL-17
4.7 ± 4.3
2.6 ± 1.3
3.4 ± 1.8
1.0 ± 0.5
TGF-1
26.3 ± 15.3
92.5 ± 28.7
67.4 ± 19.5
36.0 ± 9.9
TNF-
404.9 ± 39.5
279.8 ± 41.2
327.2 ± 31.4
540.8 ± 34.4†
Day 7
IL-1
189.8 ± 5.8
191.7 ± 5.7‡
191.9 ± 4.1
IL-6
356.4 ± 35.2
410.3 ± 12.7
389.9 ± 15.9‡
IL-10
339.3 ± 58.5
237.4 ± 41.0
276.0 ± 34.4
IL-12
1145.7 ± 337.5‡
269.5 ± 57.7
601.9 ± 152.1‡
IL-17
0.8 ± 0.4
4.6 ± 1.9
3.2 ± 1.2
TGF-1
25.3 ± 16.2
28.2 ± 11.9‡
27.1 ± 9.4‡
TNF-
434.7 ± 14.3
367.1 ± 24.5
392.8 ± 17.1
IL = interleukin; TGF = transforming growth factor; and TNF = tumor necrosis factor. compared to no-low-dose steroid group, by Mann-Whitney test. compared to all patients with severe sepsis, by Mann-Whitney test. compared within the same group on day 1, by Wilcoxon signed-rank test.